Guidance Optimizes Genotoxicity Tests, Aids in Risk Characterization By Sam | April 7, 2016 The FDA has revised its guidance on testing a new drug’s genotoxicity to help drugmakers optimize the standard genetic toxicology battery and better predict potential human risks. Posted in Washington Drug Letter